BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30178007)

  • 1. Association of Rapid Molecular Testing With Duration of Respiratory Isolation for Patients With Possible Tuberculosis in a US Hospital.
    Chaisson LH; Duong D; Cattamanchi A; Roemer M; Handley MA; Schillinger D; Sur M; Pham P; Lin MA; Goldman LE; Quan J; Perez S; Healy M; Higashi J; Winston L; Haller B; Luetkemeyer AF; Davis JL
    JAMA Intern Med; 2018 Oct; 178(10):1380-1388. PubMed ID: 30178007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of screening strategies for pulmonary tuberculosis among hospitalized patients in a low-burden setting: cost-effectiveness of GeneXpert MTB/RIF compared to smear microscopy.
    Hickey AJ; Cummings MJ; Zafari Z; Louh IK; Li J; O'Donnell MR
    Infect Control Hosp Epidemiol; 2022 Jul; 43(7):892-897. PubMed ID: 34154681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of GeneXpert MTB/RIF assay on triage of respiratory isolation rooms for inpatients with presumed tuberculosis: a hypothetical trial.
    Chaisson LH; Roemer M; Cantu D; Haller B; Millman AJ; Cattamanchi A; Davis JL
    Clin Infect Dis; 2014 Nov; 59(10):1353-60. PubMed ID: 25091300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a Single Xpert MTB/RIF Assay to Determine the Duration of Airborne Isolation in Hospitalized Patients With Suspected Pulmonary Tuberculosis.
    Poonawala H; Leekha S; Medina-Moreno S; Filippell M; Johnson JK; Redfield RR; Saharia KK
    Infect Control Hosp Epidemiol; 2018 May; 39(5):590-595. PubMed ID: 29582718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting. a hypothetical trial.
    Davis JL; Kawamura LM; Chaisson LH; Grinsdale J; Benhammou J; Ho C; Babst A; Banouvong H; Metcalfe JZ; Pandori M; Hopewell PC; Cattamanchi A
    Am J Respir Crit Care Med; 2014 Jun; 189(12):1551-9. PubMed ID: 24869625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid molecular testing for TB to guide respiratory isolation in the U.S.: a cost-benefit analysis.
    Millman AJ; Dowdy DW; Miller CR; Brownell R; Metcalfe JZ; Cattamanchi A; Davis JL
    PLoS One; 2013; 8(11):e79669. PubMed ID: 24278155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New recommendations for duration of respiratory isolation based on time to detect Mycobacterium tuberculosis in liquid culture.
    Ritchie SR; Harrison AC; Vaughan RH; Calder L; Morris AJ
    Eur Respir J; 2007 Sep; 30(3):501-7. PubMed ID: 17537768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea.
    Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T
    Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The New Xpert MTB/RIF Ultra: Improving Detection of
    Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reconsideration of the admission and discharge criteria of tuberculosis patients in Japan].
    Masuyama H; Igari H
    Kekkaku; 2013 Mar; 88(3):373-85. PubMed ID: 23672177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
    Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
    BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Xpert MTB/RIF assay for the diagnosis of smear-negative pulmonary and extrapulmonary tuberculosis in Madagascar.
    Rakotoarivelo R; Ambrosioni J; Rasolofo V; Raberahona M; Rakotosamimanana N; Andrianasolo R; Ramanampamonjy R; Tiaray M; Razafimahefa J; Rakotoson J; Randria M; Bonnet F; Calmy A;
    Int J Infect Dis; 2018 Apr; 69():20-25. PubMed ID: 29408360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
    Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased detection of smear-negative pulmonary tuberculosis by GeneXpert MTB/RIF® assay after bleach concentration.
    Tadesse M; Aragaw D; Rigouts L; Abebe G
    Int J Mycobacteriol; 2016 Jun; 5(2):211-8. PubMed ID: 27242234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMPARISON OF GeneXpert MTB/RIF ASSAY WITH CONVENTIONAL AFB SMEAR FOR DIAGNOSIS OF PULMONARY TUBERCULOSIS IN NORTHEASTERN THAILAND.
    Reechaipichitkul W; Suleesathira T; Chaimanee P
    Southeast Asian J Trop Med Public Health; 2017 Mar; 48(2):313-21. PubMed ID: 29641882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision making to discharge patients from airborne infection isolation rooms: The role of a single GeneXpert MTB/RIF strategy in Brazil.
    Menon LJB; Feliciano CS; de Campos MR; Bollela VR
    Infect Control Hosp Epidemiol; 2020 Jul; 41(7):784-788. PubMed ID: 32299529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance and impact of GeneXpert MTB/RIF® and Loopamp MTBC Detection Kit® assays on tuberculosis case detection in Madagascar.
    Rakotosamimanana N; Lapierre SG; Raharimanga V; Raherison MS; Knoblauch AM; Raherinandrasana AH; Rakotoson A; Rakotonirina J; Rasolofo V
    BMC Infect Dis; 2019 Jun; 19(1):542. PubMed ID: 31221109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.